Targeted systemic dendrimer delivery of CSF‐1R inhibitor to tumor‐associated macrophages improves outcomes in orthotopic glioblastoma-Reference-Cited by-同舟云学术

Targeted systemic dendrimer delivery of CSF‐1R inhibitor to tumor‐associated macrophages improves outcomes in orthotopic glioblastoma

Published:2020-12-11 Issue:2 Volume:6 Page:
ISSN:2380-6761
Container-title:Bioengineering & Translational Medicine
language:en
Short-container-title:Bioeng Transl Med

Author:

Liaw Kevin¹²,Reddy Rajsekhar²^ORCID,Sharma Anjali²,Li Jiangyu³,Chang Michelle¹,Sharma Rishi²,Salazar Sebastian³,Kannan Sujatha⁴,Kannan Rangaramanujam M.¹²^ORCID

Affiliation:

1. Department of Chemical and Biomolecular Engineering Johns Hopkins University Baltimore Maryland USA

2. Center for Nanomedicine, Department of Ophthalmology Johns Hopkins Medicine Baltimore Maryland USA

3. Department of Biomedical Engineering Johns Hopkins University Baltimore Maryland USA

4. Anesthesiology and Critical Care Medicine Johns Hopkins Medicine Baltimore Maryland USA

Funder

National Institute of Biomedical Imaging and Bioengineering

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/btm2.10205

Reference52 articles.

1. Adult glioma incidence trends in the United States, 1977-2000

2. Glioblastoma multiforme: a review of where we have been and where we are going

4. Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis

5. Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in nanomedicine delivery systems: unraveling immune regulation strategies for tumor immunotherapy;Nanomedicine;2024-07-16

2. Integration of Dendrimer‐Based Delivery Technologies with Computational Pharmaceutics and Their Potential in the Era of Nanomedicine;Exploring Computational Pharmaceutics ‐ AI and Modeling in Pharma 4.0;2024-06-21

3. Potential therapeutic targets in myeloid cell therapy for overcoming chemoresistance and immune suppression in gastrointestinal tumors;Critical Reviews in Oncology/Hematology;2024-06

4. New insights into the role of macrophages in cancer immunotherapy;Frontiers in Immunology;2024-03-28

5. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier;Oncology Research;2024